Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
Alleged terror plot in Detroit thwarted, two men charged with firearms and ammunition conspiracy
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
Alleged terror plot in Detroit thwarted, two men charged with firearms and ammunition conspiracy
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.